• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物性骨代谢紊乱。发病率、管理与预防

Drug-induced disorders of bone metabolism. Incidence, management and avoidance.

作者信息

Jones G, Sambrook P N

机构信息

Bone and Mineral Research Division, Garvan Institute for Medical Research, St Vincent's Hospital, Sydney, Australia.

出版信息

Drug Saf. 1994 Jun;10(6):480-9. doi: 10.2165/00002018-199410060-00006.

DOI:10.2165/00002018-199410060-00006
PMID:7917076
Abstract

Calcium homeostasis depends upon the interplay of intestinal calcium absorption, renal excretion and skeletal mobilisation of calcium, mediated through bone formation and resorption, which are closely coupled in the adult skeleton. Serum calcium is extremely important for maintenance of normal cellular functions and is regulated by the major calciotropic hormones, parathyroid hormone (PTH), 1,25-dihydroxy-vitamin D and calcitonin. Certain drugs can interfere with calcium metabolism by effects at different stages in calcium metabolism, and a knowledge of the mechanism of drug action is generally helpful in understanding the various resultant clinical skeletal syndromes. Corticosteroids, for example, have profound effects at multiple stages of calcium metabolism, resulting in decreased bone formation and enhanced bone resorption leading to accelerated osteoporosis. Drugs such as aluminium and anticonvulsants impair mineralisation, leading to osteomalacia. Other drugs, such as fluoride, are employed for their known effects on bone, but in excess dosage can be harmful by producing mineralisation defects. Management of these conditions will be discussed in this review.

摘要

钙稳态取决于肠道钙吸收、肾脏排泄以及骨骼对钙的动员之间的相互作用,这些过程通过骨形成和骨吸收来介导,在成人骨骼中它们紧密相关。血清钙对于维持正常细胞功能极为重要,并受主要的钙调节激素甲状旁腺激素(PTH)、1,25-二羟维生素D和降钙素的调节。某些药物可通过影响钙代谢的不同阶段来干扰钙代谢,了解药物作用机制通常有助于理解由此产生的各种临床骨骼综合征。例如,皮质类固醇在钙代谢的多个阶段具有深远影响,导致骨形成减少和骨吸收增强,进而导致骨质疏松加速。铝和抗惊厥药等药物会损害矿化,导致骨软化症。其他药物,如氟化物,因其对骨骼的已知作用而被使用,但过量使用可能会因产生矿化缺陷而有害。本文将讨论这些情况的管理。

相似文献

1
Drug-induced disorders of bone metabolism. Incidence, management and avoidance.药物性骨代谢紊乱。发病率、管理与预防
Drug Saf. 1994 Jun;10(6):480-9. doi: 10.2165/00002018-199410060-00006.
2
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病(未透析)患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
3
[Iatrogenic demineralizing osteopathies].[医源性脱矿性骨病]
Presse Med. 1994 Feb 12;23(6):271-3.
4
On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism.抗惊厥药物引起钙代谢改变的发病机制
Eur J Pediatr. 1982 May;138(3):202-5. doi: 10.1007/BF00441202.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
[Aging and homeostasis. Management of disorders in bone and calcium metabolism associated with ageing.].[衰老与体内平衡。与衰老相关的骨和钙代谢紊乱的管理。]
Clin Calcium. 2017;27(7):999-1005.
7
The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.原发性甲状旁腺功能亢进症中的骨骼:一篇聚焦于骨重塑、结构、骨量和骨折的综述
APMIS Suppl. 2001(102):1-52.
8
Metabolic and biochemical considerations of bone.骨骼的代谢与生化考量
Ann Clin Lab Sci. 1975 May-Jun;5(3):185-94.
9
Vitamin D signaling in calcium and bone homeostasis: a delicate balance.维生素D在钙和骨稳态中的信号传导:一种微妙的平衡。
Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):621-31. doi: 10.1016/j.beem.2015.06.001. Epub 2015 Jun 30.
10
Corticosteroid-induced osteoporosis.糖皮质激素性骨质疏松症
Endocrinol Metab Clin North Am. 1990 Mar;19(1):95-111.

引用本文的文献

1
Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications.长期服用抗惊厥药物而非抗抑郁药物会损害骨强度:临床意义。
Transl Psychiatry. 2015 Jun 2;5(6):e576. doi: 10.1038/tp.2015.38.
2
Complexation and sequestration of BMP-2 from an ECM mimetic hyaluronan gel for improved bone formation.基于透明质酸水凝胶的细胞外基质模拟物对 BMP-2 的复合和螯合作用以增强骨形成。
PLoS One. 2013 Oct 22;8(10):e78551. doi: 10.1371/journal.pone.0078551. eCollection 2013.
3
Drug-induced musculoskeletal disorders.

本文引用的文献

1
METABOLIC STUDIES OF THE EFFECTS OF METHOTREXATE.甲氨蝶呤作用的代谢研究
Metabolism. 1965 Feb;14:135-40. doi: 10.1016/s0026-0495(65)80035-x.
2
Effect of sodium fluoride on calcium metabolism of human beings.氟化钠对人体钙代谢的影响。
Nature. 1961 Jul 8;191:184-5. doi: 10.1038/191184a0.
3
Scurvy following folic acid antagonist therapy.叶酸拮抗剂治疗后发生坏血病。
药物性肌肉骨骼疾病
Drug Saf. 2007;30(1):27-46. doi: 10.2165/00002018-200730010-00004.
4
Drug-induced rheumatic disorders: incidence, prevention and management.药物性风湿性疾病:发病率、预防与管理
Drug Saf. 2000 Oct;23(4):279-93. doi: 10.2165/00002018-200023040-00002.
Radiology. 1956 Sep;67(3):412-5. doi: 10.1148/67.3.412.
4
Aluminium in antacids and cooking pots and the risk of hip fractures in elderly people.抗酸剂和炊具中的铝与老年人髋部骨折风险
Age Ageing. 1994 Nov;23(6):468-72. doi: 10.1093/ageing/23.6.468.
5
A half-century of community water fluoridation in the United States: review and commentary.美国半个世纪的社区水氟化:回顾与评论。
J Public Health Dent. 1993 Winter;53(1):17-44. doi: 10.1111/j.1752-7325.1993.tb02666.x.
6
Steroid osteoporosis.类固醇性骨质疏松症
BMJ. 1993 Aug 28;307(6903):519-20. doi: 10.1136/bmj.307.6903.519.
7
Sodium fluoride therapy of postmenopausal osteoporosis.绝经后骨质疏松症的氟化钠治疗
Endocr Rev. 1993 Jun;14(3):312-23. doi: 10.1210/edrv-14-3-312.
8
The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.类风湿关节炎及类固醇疗法对绝经后女性骨密度的影响。
Arthritis Rheum. 1993 Nov;36(11):1510-6. doi: 10.1002/art.1780361105.
9
Methotrexate osteopathy in rheumatic disease.风湿性疾病中的甲氨蝶呤性骨病
Ann Rheum Dis. 1993 Aug;52(8):582-5. doi: 10.1136/ard.52.8.582.
10
Calcium homeostasis in pregnancy and lactation.
Acta Obstet Gynecol Scand. 1993 Oct;72(7):509-13. doi: 10.3109/00016349309058153.